2017 Q1 Form 10-Q Financial Statement

#000114420417023901 Filed on May 02, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1
Revenue $10.21M $6.667M
YoY Change 53.13% -1.32%
Cost Of Revenue $4.893M $3.929M
YoY Change 24.54% 14.99%
Gross Profit $5.316M $2.738M
YoY Change 94.16% -18.0%
Gross Profit Margin 52.07% 41.07%
Selling, General & Admin $2.718M $2.379M
YoY Change 14.25% -2.2%
% of Gross Profit 51.13% 86.89%
Research & Development $330.0K $360.0K
YoY Change -8.33% -21.01%
% of Gross Profit 6.21% 13.15%
Depreciation & Amortization $687.0K $530.0K
YoY Change 29.62% 54.47%
% of Gross Profit 12.92% 19.36%
Operating Expenses $3.048M $2.739M
YoY Change 11.28% -5.17%
Operating Profit $2.268M -$2.000K
YoY Change -113500.0% -100.44%
Interest Expense $22.00K $35.00K
YoY Change -37.14% 5.02%
% of Operating Profit 0.97%
Other Income/Expense, Net -$22.00K
YoY Change
Pretax Income $2.246M -$36.00K
YoY Change -6338.89% -108.63%
Income Tax $746.0K -$13.00K
% Of Pretax Income 33.21%
Net Earnings $1.500M -$23.00K
YoY Change -6621.74% -108.27%
Net Earnings / Revenue 14.69% -0.34%
Basic Earnings Per Share $0.27 $0.00
Diluted Earnings Per Share $0.27 $0.00
COMMON SHARES
Basic Shares Outstanding 5.460M 5.423M shares
Diluted Shares Outstanding 5.533M 5.423M shares

Balance Sheet

Concept 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.870M $2.000M
YoY Change 243.5% -27.27%
Cash & Equivalents $6.869M $2.004M
Short-Term Investments
Other Short-Term Assets $1.170M $1.520M
YoY Change -23.03% 4.11%
Inventory
Prepaid Expenses
Receivables $3.790M $4.819M
Other Receivables $0.00 $20.00K
Total Short-Term Assets $11.83M $8.361M
YoY Change 41.45% -12.17%
LONG-TERM ASSETS
Property, Plant & Equipment $13.06M $13.21M
YoY Change -1.2% 4.46%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $813.0K $790.8K
YoY Change 2.8% 6.87%
Total Long-Term Assets $13.87M $14.00M
YoY Change -0.98% 4.51%
TOTAL ASSETS
Total Short-Term Assets $11.83M $8.361M
Total Long-Term Assets $13.87M $14.00M
Total Assets $25.70M $22.37M
YoY Change 14.89% -2.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $622.0K $1.295M
YoY Change -51.97% 175.53%
Accrued Expenses $2.889M $1.110M
YoY Change 160.37% -13.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.144M $1.742M
YoY Change -34.31% 24.41%
Total Short-Term Liabilities $4.655M $4.146M
YoY Change 12.27% 31.34%
LONG-TERM LIABILITIES
Long-Term Debt $1.951M $4.355M
YoY Change -55.2% -3.18%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.951M $4.355M
YoY Change -55.2% -3.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.655M $4.146M
Total Long-Term Liabilities $1.951M $4.355M
Total Liabilities $9.244M $11.35M
YoY Change -18.58% 8.63%
SHAREHOLDERS EQUITY
Retained Earnings -$4.264M -$9.134M
YoY Change -53.32% 28.74%
Common Stock $30.80M $30.23M
YoY Change 1.89% 1.97%
Preferred Stock
YoY Change
Treasury Stock (at cost) $10.08M $10.08M
YoY Change 0.0% 0.0%
Treasury Stock Shares 668.0 shares 668.1K shares
Shareholders Equity $16.45M $11.01M
YoY Change
Total Liabilities & Shareholders Equity $25.70M $22.37M
YoY Change 14.89% -2.42%

Cashflow Statement

Concept 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income $1.500M -$23.00K
YoY Change -6621.74% -108.27%
Depreciation, Depletion And Amortization $687.0K $530.0K
YoY Change 29.62% 54.47%
Cash From Operating Activities $4.402M $180.0K
YoY Change 2345.56% -61.7%
INVESTING ACTIVITIES
Capital Expenditures $153.0K $201.0K
YoY Change -23.88% 56.97%
Acquisitions
YoY Change
Other Investing Activities $3.000K -$30.00K
YoY Change -110.0% -400.0%
Cash From Investing Activities -$366.0K -$260.0K
YoY Change 40.77% 44.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.105M -610.0K
YoY Change 81.15% -47.41%
NET CHANGE
Cash From Operating Activities 4.402M 180.0K
Cash From Investing Activities -366.0K -260.0K
Cash From Financing Activities -1.105M -610.0K
Net Change In Cash 2.931M -690.0K
YoY Change -524.78% -20.69%
FREE CASH FLOW
Cash From Operating Activities $4.402M $180.0K
Capital Expenditures $153.0K $201.0K
Free Cash Flow $4.249M -$21.00K
YoY Change -20333.33% -106.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
687000 USD
CY2017Q1 us-gaap Assets Current
AssetsCurrent
11827000 USD
CY2017Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
10209000 USD
CY2016Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
6667000 USD
CY2017Q1 us-gaap Cost Of Services
CostOfServices
4893000 USD
CY2016Q1 us-gaap Cost Of Services
CostOfServices
3929000 USD
CY2017Q1 us-gaap Gross Profit
GrossProfit
5316000 USD
CY2016Q1 us-gaap Gross Profit
GrossProfit
2738000 USD
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1475000 USD
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1252000 USD
CY2017Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1243000 USD
CY2016Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1127000 USD
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
330000 USD
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
360000 USD
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
3048000 USD
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
2739000 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2268000 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2246000 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36000 USD
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
746000 USD
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-13000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
1500000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-23000 USD
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2016Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2016Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
530000 USD
CY2016Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
61000 USD
CY2017Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
55000 USD
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
175000 USD
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
163000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1280000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2050000 USD
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-750000 USD
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
92000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
177000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-752000 USD
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-88000 USD
CY2017Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
901000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
180000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4495000 USD
CY2017Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1951000 USD
CY2017Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
2638000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
10854000 USD
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
813000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
820000 USD
CY2017Q1 us-gaap Assets
Assets
25695000 USD
CY2016Q4 us-gaap Assets
Assets
25032000 USD
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
622000 USD
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1363000 USD
CY2017Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2889000 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1988000 USD
CY2017Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1144000 USD
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1144000 USD
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4655000 USD
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2237000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
2693000 USD
CY2017Q1 us-gaap Liabilities
Liabilities
9244000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
9425000 USD
CY2017Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
31000 USD
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
31000 USD
CY2017Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
30766000 USD
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
30603000 USD
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4264000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4945000 USD
CY2017Q1 us-gaap Treasury Stock Value
TreasuryStockValue
10082000 USD
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
10082000 USD
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
16451000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
15607000 USD
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25695000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25032000 USD
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
4402000 USD
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
201000 USD
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
153000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-257000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-366000 USD
CY2016Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
813000 USD
CY2017Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
819000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-608000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1105000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-685000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2931000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2004000 USD
CY2017Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
29000 USD
CY2017Q1 us-gaap Interest Paid
InterestPaid
22000 USD
CY2016Q1 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
610000 USD
CY2016Q1 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
405000 USD
CY2017Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
11000 USD
CY2016Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
371000 USD
CY2017Q1 dei Document Type
DocumentType
10-Q
CY2017Q1 dei Amendment Flag
AmendmentFlag
false
CY2017Q1 dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
CY2017Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q1 dei Entity Registrant Name
EntityRegistrantName
PSYCHEMEDICS CORP
CY2017Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000806517
CY2017Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2017Q1 dei Trading Symbol
TradingSymbol
PMD
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5460220 shares
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13055000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13358000 USD
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
58000 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
50000 USD
CY2017Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9577000 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8900000 USD
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.005
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.005
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
873 shares
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
873 shares
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000 shares
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6128 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6128 shares
CY2017Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
668 shares
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
668 shares
CY2016Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-35000 USD
CY2017Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-22000 USD
CY2017Q1 us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
3000 USD
CY2016Q1 us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
26000 USD
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
307000 shares
CY2017Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1144000 USD
CY2017Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
776000 USD
CY2017Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
287000 USD
CY2017Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
30000 USD
CY2017Q1 us-gaap Long Term Debt
LongTermDebt
3095000 USD
CY2017Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
858000 USD
CY2017Q1 us-gaap Interest Expense
InterestExpense
22000 USD
CY2016Q1 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0241 pure
CY2016Q1 us-gaap Interest Expense
InterestExpense
35000 USD
CY2017Q1 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0293 pure
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.2
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5460000 shares
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5423000 shares
CY2017Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
73000 shares
CY2016Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5533000 shares
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5423000 shares
CY2017Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
210000 USD
CY2016Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
30000 USD
CY2017Q1 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <table style="LINE-HEIGHT: 115%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.3pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.25in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="24"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 10pt"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>10.</b></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 10pt" align="justify"><b>Recent Accounting Pronouncements</b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b>&#160;</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify">In February 2016, the FASB issued ASU 2016-02, Leases, which introduces the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under previous guidance. The new standard establishes a right-of-use ("ROU") model that requires a lessee to record an ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. The new standard will become effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impacts the adoption of this accounting guidance will have on its financial statements.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify">In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers, which supersedes nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. ASU 2014-09 defines a five step process to achieve this core principle and, in doing so, more judgment and estimates may be required within the revenue recognition process than are required under existing U.S. GAAP.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify">The standard&#8217;s implementation date, as amended by ASU 2015-14, is effective for annual periods beginning after December 15, 2017, and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures). We have done a preliminary review of the impact of our pending adoption of ASU 2014-09 on our financial statements and have determined the implementation of this standard should not have a material impact on the financial statements. The Company intends to adopt the standard at the date required for public companies.</div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q1 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0276 pure

Files In Submission

Name View Source Status
0001144204-17-023901-index-headers.html Edgar Link pending
0001144204-17-023901-index.html Edgar Link pending
0001144204-17-023901.txt Edgar Link pending
0001144204-17-023901-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pmd-20170331.xml Edgar Link completed
pmd-20170331.xsd Edgar Link pending
pmd-20170331_cal.xml Edgar Link unprocessable
pmd-20170331_def.xml Edgar Link unprocessable
pmd-20170331_lab.xml Edgar Link unprocessable
pmd-20170331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v465244_10q.htm Edgar Link pending
v465244_ex31-1.htm Edgar Link pending
v465244_ex31-2.htm Edgar Link pending
v465244_ex32-1.htm Edgar Link pending
v465244_ex32-2.htm Edgar Link pending